FDA.reportPublic FDA data

Senna

Manufacturer
Bryant Ranch Prepack
Effective date
2025-06-26
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:05:52

Label at a glance#

ProductSenna
Active ingredientSENNOSIDES A AND B
Label structure15 sections

Indications and uses

relieve occasional constipation (irregularity) this product generally produces a bowel movement in 6 to 12 hours

Dosage and administration

take preferably at bedtime or as directed by a doctor do not exceed maximum dosage age starting dosage maximum dosage adults and children 12 years of age or older 2 tablets once a day 4 tablets twice a day children 6 to under 12 years 1 tablet once a day 2 tablets twice a day children 2 to under 6 years 1/2 tablet once a day 1 tablet twice a day children under 2 years ask a doctor ask a doctor

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Sennosides 8.6 mg

Purpose

OTC - PURPOSE SECTION

Stimulant Laxative

Uses

INDICATIONS & USAGE SECTION

  • relieve occasional constipation (irregularity)
  • this product generally produces a bowel movement in 6 to 12 hours

Warnings

WARNINGS SECTION

Do not use

  • Lasative products for longer than 1 week unless directed by a doctor

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden change in bowel habits that continues over a period of 2 weeks

OTC - STOP USE SECTION

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Posion Control Center right away.

Other information

SPL UNCLASSIFIED SECTION

  • each tablet contains: calcium 4 mg, sodium 3 mg
  • store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

colloidal sillicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose

Questions or comments?

OTC - QUESTIONS SECTION

Call 516-341-0666

8:30am-4:30pm ET. Mon-Fri

Directions

DOSAGE & ADMINISTRATION SECTION

take preferably at bedtime or as directed by a doctor

do not exceed maximum dosage

agestarting dosagemaximum dosage
adults and children 12 years of age or older2 tablets once a day4 tablets twice a day
children 6 to under 12 years1 tablet once a day2 tablets twice a day
children 2 to under 6 years1/2 tablet once a day1 tablet twice a day
children under 2 yearsask a doctorask a doctor

HOW SUPPLIED

How Supplied Section

Sennosides 8.6 mg: color brown (light), shape round, imprint code S5.

NDC: 71335-2360-1: 100 Tablets in a BOTTLE

NDC: 71335-2360-2: 60 Tablets in a BOTTLE

NDC: 71335-2360-3: 120 Tablets in a BOTTLE

NDC: 71335-2360-4: 56 Tablets in a BOTTLE

NDC: 71335-2360-5: 30 Tablets in a BOTTLE

NDC: 71335-2360-6: 90 Tablets in a BOTTLE

NDC: 71335-2360-7: 10 Tablets in a BOTTLE

Store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F)

Repackaged/Relabeled by:
Bryant Ranch Prepack, Inc.
Burbank, CA 91504

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Sennosides 8.6mg Tablet

Label
Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
312935sennosides 8.6 MG Oral TabletPSN1
312935sennosides, USP 8.6 MG Oral TabletSCD1
312935sennosides A and B 8.6 MG Oral TabletSY1

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71335-2360-1Senna100 in 1 BOTTLETABLET1001
71335-2360-2Senna60 in 1 BOTTLETABLET601
71335-2360-3Senna120 in 1 BOTTLETABLET1201
71335-2360-4Senna56 in 1 BOTTLETABLET561
71335-2360-5Senna30 in 1 BOTTLETABLET301
71335-2360-6Senna90 in 1 BOTTLETABLET901
71335-2360-7Senna10 in 1 BOTTLETABLET101

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
69618-064-01EA - Each69618-0649f21fc3d-1bee-49ed-9c25-df5c6414ba7512021-03-02

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71335-236071335-2360-1, 71335-2360-2, 71335-2360-3, 71335-2360-4, 71335-2360-5, 71335-2360-6, 71335-2360-7
69618-064

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
NameUNIIKind
CROSCARMELLOSE SODIUMM28OL1HH48IACT
SENNOSIDES A AND B1B5FPI42ENACTIB
MICROCRYSTALLINE CELLULOSEOP1R32D61UIACT
MAGNESIUM STEARATE70097M6I30IACT
SILICON DIOXIDEETJ7Z6XBU4IACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SennaSENNOSIDESBryant Ranch Prepackf2b14378-2b60-4533-b232-8c8647fbce782025-06-26WarningsExact identifier
ndc (package): 71335-2360-7
ndc (package): 71335-2360-5
ndc (package): 71335-2360-3
ndc (package): 71335-2360-4
ndc (package): 71335-2360-2
ndc (package): 71335-2360-6
ndc (package): 71335-2360-1
ndc (product): 71335-2360
ndc11 (package): 71335236007
ndc11 (package): 71335236004
ndc11 (package): 71335236003
ndc11 (package): 71335236001
ndc11 (package): 71335236005
ndc11 (package): 71335236006
ndc11 (package): 71335236002
spl id: e9ee7425-5a71-4b17-abd2-3df62474549f
spl set id: f2b14378-2b60-4533-b232-8c8647fbce78
SennaSENNOSIDESReliable 1 Laboratories LLCae46a611-20f2-74c8-e053-2995a90a32ce2025-01-15WarningsExact identifier
ndc (product): 69618-064

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.